1. Home
  2. BMRN vs EVRG Comparison

BMRN vs EVRG Comparison

Compare BMRN & EVRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
    SELLHOLDBUYas of 2 days ago
  • EVRG
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • BMRN 1996
  • EVRG 2017
  • Country
  • BMRN United States
  • EVRG United States
  • Employees
  • BMRN N/A
  • EVRG N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • EVRG Power Generation
  • Sector
  • BMRN Health Care
  • EVRG Utilities
  • Exchange
  • BMRN Nasdaq
  • EVRG Nasdaq
  • Market Cap
  • BMRN 13.7B
  • EVRG 13.9B
  • IPO Year
  • BMRN 1999
  • EVRG N/A
  • Fundamental
  • Price
  • BMRN $71.44
  • EVRG $67.87
  • Analyst Decision
  • BMRN Buy
  • EVRG Strong Buy
  • Analyst Count
  • BMRN 22
  • EVRG 7
  • Target Price
  • BMRN $94.00
  • EVRG $68.36
  • AVG Volume (30 Days)
  • BMRN 1.5M
  • EVRG 2.7M
  • Earning Date
  • BMRN 04-23-2025
  • EVRG 05-08-2025
  • Dividend Yield
  • BMRN N/A
  • EVRG 3.93%
  • EPS Growth
  • BMRN 153.71
  • EVRG 19.56
  • EPS
  • BMRN 2.21
  • EVRG 3.79
  • Revenue
  • BMRN $2,853,915,000.00
  • EVRG $5,847,300,000.00
  • Revenue This Year
  • BMRN $12.23
  • EVRG $3.18
  • Revenue Next Year
  • BMRN $9.90
  • EVRG $3.76
  • P/E Ratio
  • BMRN $32.37
  • EVRG $17.91
  • Revenue Growth
  • BMRN 17.97
  • EVRG 6.16
  • 52 Week Low
  • BMRN $60.63
  • EVRG $49.55
  • 52 Week High
  • BMRN $94.85
  • EVRG $69.93
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 55.89
  • EVRG 56.41
  • Support Level
  • BMRN $69.60
  • EVRG $65.88
  • Resistance Level
  • BMRN $73.18
  • EVRG $68.42
  • Average True Range (ATR)
  • BMRN 1.64
  • EVRG 1.10
  • MACD
  • BMRN -0.15
  • EVRG -0.04
  • Stochastic Oscillator
  • BMRN 63.45
  • EVRG 84.20

Stock Price Comparison Chart: BMRN vs EVRG

BMRN
EVRG
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100110120BMRN VS EVRG

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About EVRG Evergy Inc.

Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission Co. The utility has a combined rate base of approximately $20 billion, about half in Kansas and the rest split between Missouri and federal jurisdiction. Evergy is one of the largest wind energy suppliers in the US.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use